The Market Introduction of Biogen's Aduhelm Against Alzheimer's Finished After One Year: The Story
Aduhelm, a medication to treat mild stages of Alzheimer's disease, was launched by Biogen in June 2021. The approval was highly...
top of page
Search
bottom of page